293
Views
37
CrossRef citations to date
0
Altmetric
Original Articles

L-Arginine Pretreatment Reduces Intestinal Mucositis as Induced by 5-FU in Mice

, , , , , , , & show all
Pages 486-493 | Received 15 Mar 2014, Accepted 18 Nov 2014, Published online: 24 Mar 2015

REFERENCES

  • Russo G, Hadad R, Posner M, and Machtay M: Radiation treatment breaks and ulcerative mucositis in head and neck cancer. The Oncologist 13, 886–898, 2008.
  • Bowen JM, Gibson RJ, Cummins AG, and Keefe DM: Intestinal mucositis: The role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. Support Care Cancer 14, 713–731, 2006.
  • Leitão R, Ribeiro R, Bellaguarda E, Macedo F, Silva LR, et al.: Role of nitric oxide on pathogenesis of 5-Fluorouracil induced experimental oral mucositis in hamster. Cancer Chemother Pharmacol 59, 603–612, 2007.
  • McCarthy GM, Awde JD, Ghandi H, Vincent M, and Kocha WI: Risk factors associated with mucositis in cancer patients receiving 5-Fluorouracil. Oral Oncol 34, 484–490, 1998.
  • Keefe DM, Gibson RJ, and Hauer-Jensen M: Gastrointestinal mucositis. Seminars in Oncology Nursing 20, 38–47, 2004.
  • Wu LL, Chiu HD, Peng WH, Lin BR, Lu KS, et al.: Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-Fluorouracil chemotherapy model in mice. Cancer Chemother Pharmacol 68, 87–96, 2011.
  • Tooley KL, Howarth GS, and Butler RN: Mucositis and non-invasive markers of small intestinal function. Cancer Biology & Therapy 8, 753–758, 2009.
  • Sonis ST : The pathobiology of mucositis. Nature Reviews 4, 277–284, 2004.
  • Vliet MJ, Harmsen HJ, Bont, ES, and Tissing WJ: The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLOS Pathogens 6, e.1000879, 2010.
  • Sonis ST, Elting SL, Keefe D, Peterson DE, Shubert M, et al.: Perspectives on cancer therapy-induced mucosal injury. Cancer 100, 1995–2025, 2004.
  • Maeda T, Miyazono Y, Ito K, Hamada K, Sekine S, et al.: Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats. Cancer Chemother Pharmacol 65, 1117–1123, 2010.
  • Van Ye TM, Roza AM, Pieper GM, Henderson J Jr., Johnson CP, et al.:Inhibition of intestinal lipid peroxidation does not minimize morphologic damage. Journal of Surgical Research 55, 553–558, 1993.
  • Chin A and Parkos C: Pathobiology of neutrophil transepithelial migration: implications in mediating epithelial injury. Annu Rev Pathol Mech Dis 2, 111–143, 2007.
  • Sheth P, Basuroy S, Li C, Naren AP, and Rao RK: Role of phosphatidylinositol 3-kinase in oxidative stress-induced disruption of tight junctions. J Biol Chem 278, 49239–49245, 2003.
  • Rao R, Basuroy S, Rao V, Karnaky K, and Gupta A: Tyrosine phosphorylation and dissociation of occludin–ZO-1 and E-cadherin–β-catenin complexes from the cytoskeleton by oxidative stress. Biochem J 368, 471–481, 2002.
  • Picanço EA, Lopes-Paulo F, Marques RG, Diestel CF, Caetano CER: L-arginine and glycine supplementation in the repair of the irradiated colonic wall of rats. Int J Colorectal Dis 26, 561–568, 2011.
  • Morris SM Jr.: Enzymes of arginine metabolism. J Nutr 134, 2743S–2747S, 2004.
  • Thomas S, Ramachandran A, Patra S, Vidyasagar S, and Balasubramanian K: Nitric oxide protects the intestine from the damage induced by laparotomy and gut manipulation. J Surg Res 99, 25–32, 2001.
  • Öztürk H, Dokucu AI, Yağmur Y, and Sari I: Effects of supplemental L-arginine on the intestinal adaptive response after massive small-bowel resection in rats. Pediatr Surg Int 18, 332–336, 2002.
  • Coburn LA, Gong X, Singh K, Asim M, Scull BP, et al.: L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis. PLoS ONE 7, e33546, 2012.
  • Viana ML, Santos RGC, Generoso SV, Arantes RM, Correia MITD, et al.: Pretreatment with arginine preserves intestinal barrier integrity and reduces bacterial translocation in mice. Nutrition 26, 218–223, 2010.
  • Quirino IE, Cardoso VN, Santos RG, Evangelista WP, Arantes RME, et al.: The role of L-arginine and inducible nitric oxid synthase in intestinal permeability and bacterial translocation. JPEN J Parenter Enteral Nutr 37, 392–400, 2013.
  • Koppelmann T, Pollak Y, Mogilner J, Bejar J, Coran AG, et al.: Dietary L-arginine supplementation reduces methotrexate-induced intestinal mucosal injury in rats. BMC Gastroenterology 12, 1–9, 2012.
  • Ferreira TM, Leonel AJ, Melo MA, Santos RR, Cara DC, et al.: Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-Fluorouracil administration. Lipids 47, 669–678, 2012.
  • Soares PM, Mota JM, Gomes AS, Oliveira RB, Assreuy AMS, et al.: Gastrointestinal dysmotility in 5-Fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemother Pharmacol 63, 91–98, 2008.
  • Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265–275, 1951.
  • Vieira EL, Leonel AJ, Sad AP, Beltrao NR, Costa TF, et al.: Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J Nutr Biochem 23, 430–436, 2012.
  • Ren W, Chen S, Yin J, Duan J, Li T, et al.: Dietary arginine supplementation of mice alters the microbial population and activates intestinal innate immunity. J. Nutr 144, 988–995, 2014.
  • Gurbuz A, Kunzelman J, and Ratzer E: Supplemental dietary arginine accelerates intestinal mucosal regeneration and enhances bacterial clearance following radiation enteritis in rats. Journal of Surgical Research 74, 149–154, 1998.
  • Miyazono Y, Gao F, and Horie T: Oxidative stress contributes to methotrexate-induced small intestinal toxicity in rats. Scand J Gastroenterol 39, 1119–1127, 2004.
  • Han X, Wu Z, Di J, Pan Y, Zhang H, et al.: CXCL9 attenuated chemotherapy-induced intestinal mucositis by inhibiting proliferation and reducing apoptosis. Biomedicine & Pharmacotherapy 65, 547–554, 2011.
  • Azevedo OG, Oliveira RA, Oliveira BC, Zaja-Milatovic S, Araújo CV, et al.: Apolipoprotein E COG 133 mimetic peptide improves 5-Fluorouracil-induced intestinal mucositis. BMC Gastroenterology 12, 1–18, 2012.
  • Soares PM, Mota JM, Souza EP, Justino PF, Franco AX, et al.: Inflammatory intestinal damage induced by 5-Fluorouracil requires IL-4. Cytokine 61, 46–49, 2013.
  • Kubes P and McCafferty DM: Nitric oxide and intestinal inflammation. Am J Med 109, 150–158, 2000.
  • Löser C, Eisel A, Harms D, and Fölsch UR: Dietary polyamines are essential luminal growth factor for small intestinal and colonic mucosal growth and development. Gut 44, 12–16, 1999.
  • Guo X, Rao JN, Liu L, Rizvi M, Turner DJ, et al.: Polyamines regulate β-catenin tyrosine phosphorylation via Ca2+ during intestinal epithelial cell migration. Am J Physiol Cell Physiol 283, C722–C734, 2002.
  • Moinard C, Cynober L, and Bandt JP: Polyamines: Metabolism and implications in human diseases. Clin Nutr 24, 184–197, 2005.
  • Gao F, Tomitorib H, Igarashi BK, and Horie T: Correlation between methotrexate-induced intestinal damage and decrease in polyamine content. Life Sciences 72, 669–676, 2002.
  • Guo X, Rao JN, Liu L, Zou TT, Keledjian KM, et al.: Polyamines are necessary for synthesis and stability of occluding protein in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 288, G1159–G1169, 2005.
  • Liu L, Guo X, Rao JN, Zou TT, Xiao L, et al.: Polyamines regulate E-cadherin transcription through c-Myc modulating intestinal epithelial barrier function. Am J Physiol Cell Physiol 296, C801–C810, 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.